Biography
Lambson received a B.S. degree in Biochemistry (2016) from Brigham Young University. He earned his Doctor of Pharmacy degree (2021) from the University of Utah. Following his Pharm. D. degree, he completed a 2-year fellowship in clinical toxicology at the Utah Poison Control Center.
Personal Statement
Lambson was first exposed to clinical toxicology as a pharmacy intern working at the Utah Poison Control Center. He was fascinated by the clinical work provided by specialists in poison information (SPIs) on the phones. SPIs require an in-depth understanding of the pharmacology and mechanisms of toxicity of both pharmaceutical and non-pharmaceutical substances. With that knowledge, SPIs manage a large variety of calls ranging from reassuring a panicked caller of minimally toxic exposures to discussing the complex management of critically ill poisoned patients. Lambson enjoys providing this variety of care to all individuals regardless of intentionality or agent.
Lambson has additionally seen the impact a poison center can have not only on individuals and health systems but entire communities through careful collaboration with public health officials and political figures. Lambson is interested in pursuing research and scholarly work that promotes the work of poison centers including areas of pharmacovigilance, poisonings, and overdose. Most recently, Lambson has participated in research evaluating poison center workload in efforts to promote more meaningful accreditation standards that better demonstrate the service a poison center provides to the community.
Links:
https://hsc.unm.edu/poison/about/team.html
https://www.crediblemeds.org/research-scientists/scientific-review-committee
Areas of Specialty
Poisoning
Overdose
Poison Control
Workload
Pharmacovigilance
Education
PharmD, DABAT
Certifications
Diplomate of the American Board of Applied Toxicology
Specialist in Poison Information
University of Utah Management Essentials Certificate
University of Utah Teaching Certificate
CITI Good Clinical Practice Course (US FDA Focus)
CITI Group 1. Biomedical Research Investigators and Key Personnel
APhA Pharmacy-Based Immunization Delivery Certification
Languages
- French
Courses Taught
PHRM 105 - Pharmacy Practice: Toxicology (11/28/2023)
PHRM 750 - General Management & Toxicokinetics
PHRM 750 - Antidotes
Research and Scholarship
ABC Good Morning America Video Interview on Semaglutide Overdoses - 12/15/2023
https://www.goodmorningamerica.com/wellness/story/poison-control-centers-report-increase-calls-related-drugs-105685860
CNN Health Newsarticle on Semaglutide Overdoses - 12/13/2023
https://www.cnn.com/2023/12/13/health/semaglutide-overdoses-wellness/index.html
Lambson J, Johnson AR, Bennett H, Nickman N. Poison Call Center Occupancy Under Current AAPCC Accreditation Standards. North American Congress of Clinical Toxicology Annual Meeting, Montreal, 2023.
Lambson J, Hinckley P, Moss M. Rivastigmine to Treat Anticholinergic Toxicity Following Drug Overdose. North American Congress of Clinical Toxicology Annual Meeting, Montreal, 2023.
Moss M, Hinchman B, Lambson J, Rhein T, Scott J, Hinckley P, Wylie S, Dorey A. High-risk Acetaminophen Overdose Outcomes After Treatment with High-dose N-acetylcysteine. North American Congress of Clinical Toxicology Annual Meeting, Montreal, 2023.